Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$123,500.00
Jan 1, 2026
For-profit organization
Accelerating In-house Genetics and Embryo Development
1037898
This project will establish an in-house, automated Drosophila embryo microinjection platform to generate transgenic fly lines for R&D and commercial use. This will reduce costs and shorten timelines from plasmid to transgenic fly lines, and enable earlier testing of more construct variants, strengthening Alberta’s bio-based manufacturing capacity.
$1,787,499.11
Mar 4, 2025
For-profit organization
Scaling the Production of Recombinant Proteins Produced In Genetically Engineered Drosophila
1029505
Future Fields is an Edmonton-based biotech company that produces the most cost-effective and sustainable recombinant proteins in the world. The company has developed a novel insect-based expression platform that circumvents the challenges associated with legacy systems. In just 2 years, they have already launched 3 different products that are tailored to the needs of the cellular agriculture industry, a new and exciting field where traditional agriculture products, like milk or meat, can be created by culturing cells instead of raising animals.